Search Results - S. Foraida
- Showing 1 - 8 results of 8
-
1
-
2
Integrated In Vivo and In Vitro Evaluation of a Powder-to-Hydrogel, Film-Forming Polymer Complex Base with Tissue-Protective and Microbiome-Supportive Properties by Daniel Banov, Guiyun Song, Zahraa Foraida, Oksana Tkachova, Oleksandr Zdoryk, Maria Carvalho
Published in Gels (2024-07-01)Get full text
Article -
3
Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in Pakistan by M.A. Khan, A. Ismail, A. Ghafoor, N. Khan, N. Muzaffar, F. Zafar, A. Gupta, S. Foraida, S. Juneja, R. Fatima, A.W. Khan, S. Shahid, M.A. Khan
Published in IJTLD Open (2024-11-01)Get full text
Article -
4
Treatment success rate and time to culture conversion under a prospective BPaL cohort study by E. Burhan, J. Sugiharto, M. Soemarno, A. Juan, Y. Runtu, A. Yuvensia, R. Ramadhani, J. Sabono, A. Lailiyah, F. Fenni, M. Farikha, T. Pakasi, I. Pambudi, M. Mbenga, I. Koppelaar, V. Mirtskhulava, F. Wares, D. Jerene, J.K. Jung, J.S. Lee, S. Foraida, S. Juneja, M. Diachenko, A. Gebhard
Published in IJTLD Open (2025-05-01)Get full text
Article -
5
Introducing BPaL: Experiences from countries supported under the LIFT-TB project. by D F Wares, M Mbenga, V Mirtskhulava, M Quelapio, A Slyzkyi, I Koppelaar, S N Cho, U Go, J S Lee, J-K Jung, D Everitt, S Foraida, M Diachenko, S Juneja, E Burhan, A Totkogonova, Z Myint, I Flores, N A Lytvynenko, N Parpieva, N V Nhung, A Gebhard
Published in PLoS ONE (2024-01-01)Get full text
Article -
6
Introducing BPaL: Experiences from countries supported under the LIFT-TB project by D. F. Wares, M. Mbenga, V. Mirtskhulava, M. Quelapio, A. Slyzkyi, I. Koppelaar, S. N. Cho, U. Go, J. S. Lee, J.-K. Jung, D. Everitt, S. Foraida, M. Diachenko, S. Juneja, E. Burhan, A. Totkogonova, Z. Myint, I. Flores, N. A. Lytvynenko, N. Parpieva, N. V. Nhung, A. Gebhard
Published in PLoS ONE (2024-01-01)Get full text
Article -
7
Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/X... by Kogieleum Naidoo, Derek J Sloan, Wilber Sabiiti, Bariki Mtafya, Stephen H Gillespie, Aderonke Agbaje, Nyanda Elias Ntinginya, Morten Ruhwald, Agnes Gebhard, Anushka Naidoo, Rubeshan Perumal, Getachew Tollera, Evaezi Okpokoro, Alash'le G Abimiku, Everdina W Tiemersma, Sabine M Hermans, Sophia B Georghiou, Kalkidan Yae, Shewki Moga, Hannelise Feyt, Takondwa Kachoka, Marothi P Letsoalo, Andrea M Cabibbe, Letitia Shunmugam, Daniela M Cirillo, Salah Foraida
Published in BMJ Open (2024-11-01)Get full text
Article -
8
ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis by Linda J. Harrison, Gustavo E. Velásquez, Russell R. Kempker, Marjorie Z. Imperial, Eric Nuermberger, Susan E. Dorman, Elisa Ignatius, Janeway Granche, Patrick P. J. Phillips, Jennifer Furin, Eunsol Yang, Colleen Foley, Shawn Chiambah, Rochelle Rogers, Austin Van Grack, Jhoanna Roa, Justin Shenje, Sandy Nerette, Cecilia Kanyama, Rachel Bakyayita Kyeyune, Alberto Mendoza-Ticona, William Murtaugh, Salah Foraida, Melanie Goth, Andrew Vernon, Kelly E. Dooley, Radojka M. Savic
Published in Trials (2025-08-01)Get full text
Article
